Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InMed Pharmaceuticals (INM) Non Operating Income: 2023-2024

  • InMed Pharmaceuticals' Non Operating Income fell 30.29% to $103,421 in Q2 2024 from the same period last year, while for Jun 2024 it was $528,803, marking a year-over-year change of. This contributed to the annual value of $527,901 for FY2024, which is 7.20% up from last year.
  • According to the latest figures from Q2 2024, InMed Pharmaceuticals' Non Operating Income is $103,421, which was down 14.85% from $121,458 recorded in Q1 2024.
  • Over the past 5 years, InMed Pharmaceuticals' Non Operating Income peaked at $155,567 during Q1 2023, and registered a low of $103,421 during Q2 2024.
  • Over the past 2 years, InMed Pharmaceuticals' median Non Operating Income value was $134,908 (recorded in 2023), while the average stood at $132,201.
  • Data for InMed Pharmaceuticals' Non Operating Income shows a maximum YoY plummeted of 30.29% (in 2024) over the last 5 years.
  • InMed Pharmaceuticals' Non Operating Income (Quarterly) stood at $148,357 in 2023, then slumped by 30.29% to $103,421 in 2024.
  • Its last three reported values are $103,421 in Q2 2024, $121,458 for Q1 2024, and $148,357 during Q2 2023.